Biotech

All Articles

Navigator raises $100M to cultivate new autoimmune pipe

.Sat nav Medicines has equipped on its own with $one hundred thousand in set A funds as the younger ...

Duality finds money for ADC tests as IPO wave infects Asia

.China's Duplicity Biotherapeutics has submitted (PDF) documents for a Hong Kong IPO, looking for an...

YolTech offers China civil rights to genetics editing treatment for $29M

.4 months after Mandarin gene modifying provider YolTech Therapies took its own cholesterol levels d...

Addex inventory increases after Indivior provides to $300M for material

.Indivior is actually picking up a small particle allosteric modulator made to manage substance use ...

Molecular Partners fine-tunes AML test over 'suboptimal visibility'

.Molecular Companions has actually pinpointed "suboptimal exposure" to its tetra-specific T-cell eng...

Despite combined market, a venture capital rebirth could be coming in Europe: PitchBook

.While the biotech financial investment performance in Europe has slowed rather adhering to a COVID-...

8 months after a $213M fundraise, genetics editor Volume helps make reduces

.After bring up $213 million in 2023-- some of the year's largest private biotech shots-- Tome Biosc...

BioMarin creates officer group with biotech vets-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and retir...

Biopharma Q2 VC struck highest level given that '22, while M&ampA decreased

.Venture capital financing right into biopharma rose to $9.2 billion across 215 deals in the second ...

Bicara, Zenas find IPOs to push late-phase properties toward market

.Bicara Rehabs as well as Zenas Biopharma have delivered fresh impetus to the IPO market along with ...